- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02886039
Predictive Electrophysiological Score of the Neurological Prognosis Post Cardiac Arrest (CA-EEG)
Cardiac arrest (CA) is a major public health problem (1) because of its frequency (30000 to 50000 new cases of CA per year in France), a high mortality 80-90% and a relevant morbidity : 50% of survivors have cerebral sequela. Neurologic prognostication after CA is paramount. The American Academy of Neurology identifies accurate predictors of poor neurologic outcome (2): clinical examination findings such as no pupil response, no corneal reflexes, no motor response to stimulation and early myoclonus status epilepticus; biologic parameters like high neuron specific enolase (NSE) greater than 33 μg/L (3-4) and electrophysiologic results like flat electroencephalogram (EEG) or with burst suppression and Somatosensory evoked potentials (SEP) with no response to N20. Brain imaging may provide additional informations but not recommended yet. However, these pronotic markers were developed before the introduction therapeutic hypothermia (TH) (5-6). TH is now recommended after cardiac arrest by international guidelines, based on demonstration of improved survival and neurological recovery in comatose survivors of CA (7). TH and its associated use of sedative and paralytic agent may delay neurologic recovery and affect the optimal timing of prognostic variables (8).
Many classifications of electroencephalogram (EEG) (9-12) exist but no one is generally accept and recommended and they were created before TH.
In a preliminary study based on a retrospective cohort of 64 patients in CA with initial TH, we developped an electroencephalographic score to predict precocity the neurologic outcome according to the Cerebral performance category (CPC) (13-14).
The purpose of this study is to evaluate a simple and objective electroencephalographic score helpful to predict neurologic outcome after CA. Then, we would like to create a composite score to have a multimodal prognostication.
Patients and methods After CA resuscitation, all patients underwent coronary angioplasty if indicated and then were immediately admitted in emergency room of ICU. All patients were intubated and mechanically ventilated. Sedation was performed with continuous infusion of midazolam 0,15-0,2 mg/kg/h and sufentanil 0,15-0,2 μg/kg/h. All our patients were curarized with cisatracurium 0,2-0,3 mg/kg/h to prevent shivering during TH and took anti-epileptic medication phenobarbital 10-15 mg/ kg two times a day to prevent infra-clinic convulsive seizure.
Mild TH between 33 -34 °C was performed by active cooling with intravascular device (CoolGard® - Zoll, Chelmsford, UK) for 24 hours. Mean arterial pressure was maintained between [75-80] mmHg by titrated norepinephrine with or without inotropics (dobutamine, epinephrine) according cardiac output monitored by echocardiography.
After 24 hours of hypothermia, warming was started at a rate of 0.2 ° C/hr; neuromuscular blocking agents were arrested at 35.5°C and sedation at 36.5°C.
Neurological evaluation performed at 48 hours off sedation included a clinical evaluation (Glasgow score, myoclonus status, response to orders, motor response to stimulation, brain-stem reflexes). NSE was sampled between 48 and 72 H. EEGs were performed at Day-2, Day-3 and Day-5 off sedation and SEP at Day-5 off sedation. All EEGs were interpreted by two certified electroencephalographers blind from clinical neurologic outcome.
Survival and neurologic outcome according to CPC were assessed at ICU discharge and three months later.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Electroencephalographic score
Reactivity Absence 1 Presence 0 Dominant frequency α (8-12 Hz) 0 θ (4-7,5 Hz) 1 δ (< 4 Hz) 2 Amplitude > 10 μV 0 < 10 μV 1 GPDs Absence 0 Presence 1 Burst Suppression Absence 0 Presence 1 Paroxysmal activity Absence 0 Presence 1
TOTAL
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jean Paul ROUSTAN, MD, PhD
- Phone Number: 04 67 33 82 56
- Email: JP-ROUSTAN@CHU-MONTPELLIER.FR
Study Locations
-
-
-
Montpellier, France, 34295
- Recruiting
- Hôpital Lapeyronie - Département Anesthésie Réanimation A
-
Contact:
- Jean-Paul ROUSTAN, MH, PhD
- Phone Number: 04 67 33 82 56
- Email: JP-ROUSTAN@CHU-MONTPELLIER.FR
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient > 18 years, hospitalized in resuscitation
- Cardiac arrest in hospital or out
- Collection of the written and informed consent
Exclusion Criteria:
- Cardiorespiratory arrest concomitant with a neurological, traumatic or toxic pathology
- History of cerebrovascular accident or cerebral anoxia
- Patient whose family did not give an informed consent
- Patient < 18 years
Study Plan
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: patients
Patient with cardiac arrest benefiting an electroencephalogram
|
Prognostic evaluation of electroencephalogram score created with a retrospective cohort Creation of composite score to predict neurologic outcome in cardiorespiratory arrest
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
comparison of electroencephalogram score to neurologic outcome evaluated by cerebral performance category
Time Frame: J0 (date of inclusion)
|
Intensive care unit discharge
|
J0 (date of inclusion)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
comparison of electroencephalogram score to neurologic outcome evaluated by cerebral performance category
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jean Paul ROUSTAN, MD, PhD, Montpellier University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UF 9389
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiorespiratory Arrest
-
Assiut UniversityUnknownAssess the Quality Ofmanagement of Children With Cardiorespiratory Arrest in Assuit University Children Hospital According to the( A H A)Guidelines
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Hospital Universitari Joan XXIII de Tarragona.Not yet recruitingCardiopulmonary Arrest With Successful Resuscitation | Cardiorespiratory ArrestSpain
-
Universitair Ziekenhuis BrusselUnknownCardiorespiratory Arrest | MicrocirculationBelgium
-
Odense University HospitalCompletedCardiac Arrest | Neurological Complication | Post-Cardiorespiratory Arrest ComaDenmark
-
Wilfrid Laurier UniversityRecruitingCardiorespiratory FitnessCanada
-
Riphah International UniversityRecruiting
-
Duke UniversityRecruitingCardiorespiratory FitnessUnited States
-
Duke UniversityCompleted
-
University of NottinghamCompletedCardiorespiratory FitnessUnited Kingdom
-
University of British ColumbiaCompletedCardiorespiratory FitnessCanada
Clinical Trials on Electroencephalogram
-
Rambam Health Care CampusNot yet recruitingFetal Hypoxia
-
Baptist Health South FloridaFlorida International UniversityWithdrawnMajor Depression | Repetitive Transcranial Magnetic StimulationUnited States
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Federal University of ParaíbaRecruitingStroke | ElectroencephalogramBrazil
-
Centre Hospitalier Henri LaboritRecruitingSchizophrenia | Schizoaffective DisorderFrance
-
Rennes University HospitalTerminated
-
XuanwuH 2Beijing Institute of TechnologyCompletedAlzheimer Disease | Electroencephalogram | Neurofeedback | Subjective Cognitive DeclineChina
-
Centre Hospitalier Universitaire, AmiensRecruitingNeonatal Encephalopathy | Anoxia-Ischemia, BrainFrance
-
Air Force Military Medical University, ChinaRecruitingPostoperative Cognitive Dysfunction | Aging | EEG With Periodic AbnormalitiesChina
-
University of Wisconsin, MadisonCompleted